Cancer Research UK logo.
SearchDonate
  • Search

A trial of ASA404 and chemotherapy for non small cell lung cancer that has spread (ATTRACT 1)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Results

Phase:

Phase 3

Details

This trial was looking at a drug called ASA404 in combination with paclitaxel and carboplatin for non small cell lung cancer (NSCLC) that was stage 3B or 4.

Doctors often use chemotherapy to treat NSCLC that is or has spread to another part of the body. Paclitaxel and carboplatin are chemotherapy drugs that may be used.

Cancer cells need a blood supply to help them grow and survive. Growing cancer cells can stimulate the growth of new blood vessels. This is called angiogenesis.

Recruitment start: 8 April 2008

Recruitment end: 20 May 2010

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Eisen

Supported by

Novartis

Last reviewed: 16 Oct 2012

CRUK internal database number: 2749

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.